In this comprehensive guide to improving patient retention in clinical trials, we explore the impact of a high level of patient focus and support on recruitment and retention rates. We’ll also offer our expert insight into key ways to prioritise patients at every stage of the clinical journey.
Decentralisation of clinical trials has been a growing topic of discussion and development over the last few years, enabled further by the advancement of available technologies. Here, we explore what we mean when we talk about decentralised trials and discuss why the clinical research industry has been reluctant to pursue this route. We illuminate the […]
Patient influence in clinical trials is extending, from understanding patients’ needs and engaging them in the clinical development process, to giving patients the freedom to choose what’s right for them. In a recent virtual conference presentation, our VP, Patient Engagement, Vale Nicoli-Carr, talked about how we need to take our understanding of patients’ needs and put patients in the driving seat in clinical trials.
In the third of our series of mdWebinars, our panel discussed the reasons why patients drop out and what can be done to reduce the burden of trial participation for patients, and improve patient engagement and retention.
Our webinar panel discussed the challenges with new clinical trial technologies and how to deploy technologies that can deliver greater patient insight and engagement to ultimately improve patients’ safety and their trial experience.
The clinical trial landscape has changed dramatically since the outbreak of COVID-19. For the clinical research industry, these past few months have been anything but business as usual. However, it hasn’t meant clinical trials can’t continue, and many in the industry have been working together to find a ‘new normal’.
